Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

This combination does not exist.

Add to cart Buy now

More Information

This content will be shared across all product pages.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

Share

Customer Reviews